Literature DB >> 17223007

Polymorphic analysis of the matrix metalloproteinase-9 gene and susceptibility to sporadic abdominal aortic aneurysm.

Chiara Armani1, Michele Curcio, Maria Chiara Barsotti, Tatiana Santoni, Rossella Di Stefano, Matteo Dell'omodarme, Maria Luisa Brandi, Mauro Ferrari, Fabrizio Scatena, Angelo Carpi, Alberto Balbarini.   

Abstract

Abdominal aortic aneurysm (AAA) has a multifactorial aetiology and the importance of genetic components is getting increasing interest. Alteration in the structure of the vascular extracellular matrix has been described in AAA. Matrix metalloproteinases (MMPs) degrade extracellular matrix proteins which alter the vessel wall stability. We evaluated two different polymorphisms, a CA repeat and a cytosine to thymidine transition in the promoter sequence of MMP-9 gene for frequency in 146 patients with AAA. We compared the results with those of 156 healthy subjects. No difference was found in the allelic distribution of either polymorphisms. We therefore found no evidence that MMP-9 is a marker of susceptibility for AAA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17223007     DOI: 10.1016/j.biopha.2006.12.002

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  8 in total

Review 1.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.

Authors:  Mina M Benjamin; Raouf A Khalil
Journal:  Exp Suppl       Date:  2012

Review 2.  Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.

Authors:  Xi Wang; Raouf A Khalil
Journal:  Adv Pharmacol       Date:  2017-09-19

Review 3.  Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.

Authors:  Jie Liu; Raouf A Khalil
Journal:  Prog Mol Biol Transl Sci       Date:  2017-05-10       Impact factor: 3.622

Review 4.  Genes and abdominal aortic aneurysm.

Authors:  Irene Hinterseher; Gerard Tromp; Helena Kuivaniemi
Journal:  Ann Vasc Surg       Date:  2010-12-13       Impact factor: 1.466

5.  Tissue inhibitor of metalloproteinase-1 (TIMP-1) polymorphisms in a Caucasian population with abdominal aortic aneurysm.

Authors:  Irene Hinterseher; Dietmar Krex; Eberhard Kuhlisch; Karl G Schmidt; Christian Pilarsky; Wolfgang Schneiders; Hans D Saeger; Hendrik Bergert
Journal:  World J Surg       Date:  2007-11       Impact factor: 3.352

6.  Association of the TGF-beta receptor genes with abdominal aortic aneurysm.

Authors:  A F Baas; J Medic; R van 't Slot; C G de Kovel; A Zhernakova; R H Geelkerken; S E Kranendonk; S M van Sterkenburg; D E Grobbee; A P Boll; C Wijmenga; J D Blankensteijn; Y M Ruigrok
Journal:  Eur J Hum Genet       Date:  2009-08-12       Impact factor: 4.246

7.  Background differences in baseline and stimulated MMP levels influence abdominal aortic aneurysm susceptibility.

Authors:  Matthew A Dale; Melissa K Suh; Shijia Zhao; Trevor Meisinger; Linxia Gu; Vicki J Swier; Devendra K Agrawal; Timothy C Greiner; Jeffrey S Carson; B Timothy Baxter; Wanfen Xiong
Journal:  Atherosclerosis       Date:  2015-10-08       Impact factor: 5.162

8.  Matrix metalloproteinase-9 genotype as a potential genetic marker for abdominal aortic aneurysm.

Authors:  Tyler Duellman; Christopher L Warren; Peggy Peissig; Martha Wynn; Jay Yang
Journal:  Circ Cardiovasc Genet       Date:  2012-08-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.